Incretin Receptor Ligands

GLP-1S vs GLP-2T

GLP-1S and GLP-2T are both lipidated incretin-receptor ligands used in receptor pharmacology research. The critical distinction is receptor selectivity: GLP-1S is a single-target GLP-1 receptor agonist, while GLP-2T is a dual GIP/GLP-1 receptor agonist.

Side-by-Side Comparison

PropertyGLP-1SGLP-2T
CategoryGLP-1 receptor agonist (single agonist)GIP/GLP-1 dual receptor agonist (twincretin)
Mechanism of ActionActivates the GLP-1 receptor, a Gs-coupled GPCR, raising intracellular cAMP in receptor-expressing cell linesActivates both GIP and GLP-1 receptors; used to study dual incretin receptor signaling and cAMP responses
Molecular Weight~4,113 Da~4,810 Da
Research FocusGLP-1 receptor binding and signaling assaysDual GIP/GLP-1 receptor signaling and biased-agonism assays
Receptor TargetGLP-1 receptor (selective)GIP receptor (primary) + GLP-1 receptor (secondary)
Half-Life~7 days (albumin binding via C-18 fatty diacid)~5 days (C-20 fatty diacid moiety enables albumin binding)

Key Differences

  • GLP-1S targets a single receptor (GLP-1R), while GLP-2T simultaneously activates two incretin receptors (GIP and GLP-1), a distinct receptor pharmacology profile.
  • The two peptides carry different fatty diacid side chains (C-18 vs C-20), which changes their albumin-binding properties.
  • GLP-1S has a longer reported half-life (~7 days vs ~5 days), primarily due to differences in the fatty acid side chain modifications.
  • Receptor-selectivity assays commonly pair the two to separate GLP-1R-mediated signaling from combined GIPR/GLP-1R signaling.

Research Summary

The fundamental difference between GLP-1S and GLP-2T lies in receptor pharmacology. GLP-1S is a selective GLP-1 receptor agonist. GLP-2T introduces a dual agonist mechanism targeting both GIP and GLP-1 receptors. Both peptides have extended half-lives through albumin-binding fatty acid modifications, which is relevant to assay design and stability studies.

How does GLP-1S compare to GLP-2T?

GLP-1S is a selective GLP-1 receptor agonist with a ~7-day half-life, while GLP-2T is a dual GIP/GLP-1 receptor agonist with a ~5-day half-life. The key distinction is that GLP-2T activates two incretin receptors simultaneously, which makes the pair useful for comparing single-receptor and dual-receptor signaling in cell-based assays.

Disclaimer: All compounds referenced on this page are sold for research and laboratory use only. The comparisons presented are based on published scientific literature and are intended for educational and informational purposes. This content does not constitute medical advice. Researchers should consult primary literature and applicable regulations before designing study protocols.